Paul D. Scanlon

8.9k total citations · 3 hit papers
86 papers, 5.0k citations indexed

About

Paul D. Scanlon is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Epidemiology. According to data from OpenAlex, Paul D. Scanlon has authored 86 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Pulmonary and Respiratory Medicine, 33 papers in Physiology and 10 papers in Epidemiology. Recurrent topics in Paul D. Scanlon's work include Chronic Obstructive Pulmonary Disease (COPD) Research (43 papers), Asthma and respiratory diseases (27 papers) and Respiratory Support and Mechanisms (19 papers). Paul D. Scanlon is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (43 papers), Asthma and respiratory diseases (27 papers) and Respiratory Support and Mechanisms (19 papers). Paul D. Scanlon collaborates with scholars based in United States, Canada and United Kingdom. Paul D. Scanlon's co-authors include John E. Connett, William C. Bailey, A. Sonia Buist, Lance A. Waller, Ryan Clay, Matthew Koslow, Shireen Mirza, Kenneth C. Beck, Robert E. Hyatt and Edwin K. Silverman and has published in prestigious journals such as Science, New England Journal of Medicine and Journal of Clinical Oncology.

In The Last Decade

Paul D. Scanlon

85 papers receiving 4.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Changes in Forced Expiratory Volume in 1 Second over Time in COPD

2011 680 citations Paul D. Scanlon, Edwin K. Silverman et al. profile →
Smoking Cessation and Lung Function in Mild-to-Moderate Chronic Obstructive Pulmonary Disease: The Lung Health Study

2000 554 citations Paul D. Scanlon, John E. Connett et al. American Journal of Respiratory and Critical Care Medicine profile →
COPD Guidelines: A Review of the 2018 GOLD Report

2018 318 citations Paul D. Scanlon et al. Mayo Clinic Proceedings profile →

Peers

Countries citing papers authored by Paul D. Scanlon

Since Specialization

Citations

This map shows the geographic impact of Paul D. Scanlon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul D. Scanlon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul D. Scanlon more than expected).

Fields of papers citing papers by Paul D. Scanlon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul D. Scanlon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul D. Scanlon. The network helps show where Paul D. Scanlon may publish in the future.

Co-authorship network of co-authors of Paul D. Scanlon

This figure shows the co-authorship network connecting the top 25 collaborators of Paul D. Scanlon. A scholar is included among the top collaborators of Paul D. Scanlon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul D. Scanlon. Paul D. Scanlon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Aerosol Generation and Mitigation During Methacholine Bronchoprovocation Testing: Infection Control Implications in the Era of COVID-19 2021 ·Respiratory Care ·(unknown), (unknown), (unknown), (unknown), (unknown), Bruce D. Johnson, Chul‐Ho Kim, Kaiser G. Lim, Scott A. Helgeson, Paul D. Scanlon, Alexander S. Niven	2
2	Impact of hepatopulmonary syndrome in liver transplantation candidates and the role of angiogenesis 2021 ·European Respiratory Journal ·Steven M. Kawut, Michael J. Krowka, Kimberly A. Forde, Nadine Al‐Naamani, Karen Krok, Mamta Patel, Carlo Bartoli, Margaret F. Doyle, Jude Moutchia, Grace Lin, Jae K. Oh, Carl Mottram, Paul D. Scanlon, Michael B. Fallon	19
3	Pulmonary Function Tests for the Generalist: A Brief Review 2018 ·Mayo Clinic Proceedings ·Timothy Dempsey, Paul D. Scanlon	40
4	Clinical Impact of Intrapulmonary Vascular Dilatation in Candidates for Liver Transplant 2017 ·CHEST Journal ·Hilary M. DuBrock, Michael J. Krowka, Kimberly A. Forde, Karen Krok, Mamta Patel, Tiffany Sharkoski, Michael H. Sprys, Grace Lin, Jae K. Oh, Carl Mottram, Paul D. Scanlon, Michael B. Fallon, Steven M. Kawut	14
5	The sawtooth sign is predictive of obstructive sleep apnea 2016 ·Sleep And Breathing ·(unknown), Paul D. Scanlon, Darrell R. Schroeder, Eric J. Olson	3
6	Incident Pneumonia and Mortality in Patients with Chronic Obstructive Pulmonary Disease. A Double Effect of Inhaled Corticosteroids? 2014 ·American Journal of Respiratory and Critical Care Medicine ·Emir Festić, Paul D. Scanlon	45
7	Predictors of Chronic Obstructive Pulmonary Disease Exacerbation Reduction in Response to Daily Azithromycin Therapy 2014 ·American Journal of Respiratory and Critical Care Medicine ·MeiLan K. Han, Nabihah Tayob, Susan Murray, Mark T. Dransfield, George R. Washko, Paul D. Scanlon, Gerard J. Criner, Richard Casaburi, John E. Connett, Stephen C. Lazarus, Richard Albert, Prescott G. Woodruff, Fernando J. Martínez	118
8	Sputum PGP is reduced by azithromycin treatment in patients with COPD and correlates with exacerbations 2013 ·BMJ Open ·Philip O’Reilly, Patricia L. Jackson, J. Michael Wells, Mark T. Dransfield, Paul D. Scanlon, J. Edwin Blalock	32
9	Spirometric Predictors of Lung Function Decline and Mortality in Early Chronic Obstructive Pulmonary Disease 2012 ·American Journal of Respiratory and Critical Care Medicine ·Michael Drummond, Nadia N. Hansel, John E. Connett, Paul D. Scanlon, Donald P. Tashkin, Robert A. Wise	76
10	Genetic Variants Associated with the Risk of Chronic Obstructive Pulmonary Disease with and without Lung Cancer 2011 ·Cancer Prevention Research ·Mariza de Andrade, Yan Li, Randolph S. Marks, Claude Deschamps, Paul D. Scanlon, (unknown), Ruoxiang Jiang, Stephen J. Swensen, Zhifu Sun, Julie M. Cunningham, Jason A. Wampfler, Andrew H. Limper, David E. Midthun, Ping Yang	19
11	Superior Immune Response to Protein-Conjugate versus Free Pneumococcal Polysaccharide Vaccine in Chronic Obstructive Pulmonary Disease 2009 ·American Journal of Respiratory and Critical Care Medicine ·Mark T. Dransfield, Moon H. Nahm, MeiLan K. Han, Sarah Harnden, Gerard J. Criner, Fernando J. Martínez, Paul D. Scanlon, Prescott G. Woodruff, George R. Washko, John E. Connett, Nicholas R. Anthonisen, William C. Bailey	68
12	Genetic Determinants of Emphysema Distribution in the National Emphysema Treatment Trial 2007 ·American Journal of Respiratory and Critical Care Medicine ·Dawn L. DeMeo, Craig P. Hersh, Eric A. Hoffman, Augusto A. Litonjua, Ross Lazarus, David Sparrow, Joshua O. Benditt, Gerard J. Criner, Barry J. Make, Fernando J. Martínez, Paul D. Scanlon, Frank C. Sciurba, James P. Utz, John J. Reilly, Edwin K. Silverman	111
13	Loss of Bone Density with Inhaled Triamcinolone in Lung Health Study II 2004 ·American Journal of Respiratory and Critical Care Medicine ·Paul D. Scanlon, John E. Connett, Robert A. Wise, Donald P. Tashkin, Thelma C. Madhok, M.A. Skeans, Paul C. Carpenter, William C. Bailey, A. Sonia Buist, Michael S. Eichenhorn, Richard E. Kanner, Gail Weinmann	83
14	THE PATHOGENESIS AND PATHOLOGY OF COPD: IDENTIFYING RISK FACTORS AND IMPROVING MORBIDITY AND MORTALITY * 2004 ·Paul D. Scanlon	4
15	Current Practice in Pulmonary Function Testing 2003 ·Mayo Clinic Proceedings ·Scott E. Evans, Paul D. Scanlon	27
16	The correlation of emphysema or airway obstruction with the risk of lung cancer: a matched case-controlled study 2002 ·European Respiratory Journal ·(unknown), J W Gurney, Darrell R. Schroeder, Paul D. Scanlon, Stephen J. Swensen, James R. Jett	73
17	Smoking Cessation and Lung Function in Mild-to-Moderate Chronic Obstructive Pulmonary Disease: The Lung Health Study breakdown → 2000 ·American Journal of Respiratory and Critical Care Medicine ·Paul D. Scanlon, John E. Connett, Lance A. Waller, (unknown), William C. Bailey, A. Sonia Buist	554
18	Bronchoconstriction Occurring During Exercise in Asthmatic Subjects 1994 ·American Journal of Respiratory and Critical Care Medicine ·Ken C. Beck, (unknown), Paul D. Scanlon	82
19	Methacholine Inhalation Challenge 1994 ·Mayo Clinic Proceedings ·Paul D. Scanlon, Kenneth C. Beck	9
20	Respiratory Mechanics in Acute Quadriplegia: Lung and Chest Wall Compliance and Dimensional Changes during Respiratory Maneuvers 1989 ·American Review of Respiratory Disease ·Paul D. Scanlon, (unknown), (unknown), F. Dennis McCool, A. S. Slutsky, M. Sarkarati, Robert W. Brown	60

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact